scispace - formally typeset
C

C. Shad Thaxton

Researcher at Northwestern University

Publications -  104
Citations -  10390

C. Shad Thaxton is an academic researcher from Northwestern University. The author has contributed to research in topics: Cancer & Colloidal gold. The author has an hindex of 36, co-authored 101 publications receiving 9704 citations. Previous affiliations of C. Shad Thaxton include International Institute of Minnesota.

Papers
More filters
Journal ArticleDOI

Comparison of prostate specific antigen velocity in screened versus referred patients with prostate cancer.

TL;DR: Prostate specific antigen velocity more than 2 ng/ml per year has been linked to a significantly greater risk of prostate cancer specific mortality, suggesting that screen detected prostate cancer may be more likely to be cured with definitive therapy.
Journal ArticleDOI

Knockdown of intraislet IKKβ by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances graft survival.

TL;DR: Results are consistent with the hypothesis that inhibition of intraislet NF-&kgr;B activation ameliorates the detrimental effects of host cytokines and demonstrates that preconditioning freshly isolated islets in culture with IKK&bgr; SNA-NCs may be a promising therapy to enhance islet graft function and survival after transplantation.
Posted ContentDOI

Induction of DISE in ovarian cancer cells in vivo

TL;DR: In this paper, a form of off-target effect DISE (for death induced by survival gene elimination) was proposed for cancer cells in the absence of the target by targeting the 3′UTRs of critical survival genes through canonical RNAi.
Journal ArticleDOI

Mosaic Interdigitated Structure in Nanoparticle-Templated Phospholipid Bilayer Supports Partial Lipidation of Apolipoprotein A-I.

TL;DR: The discontinuous lipid milieu supports partial lipidation of apolipoprotein A-I, different from an ordinary phospholipid bilayer, suggesting that synergy between nanoparticle templates and bound phospholIPid layers can modulate amphiphilic proteins for desired functions.
Patent

High density lipoprotein nanoparticles for inflammation

TL;DR: In this paper, the use of nanoparticles having a core and a lipid based shell with optimal lipids therein is described, which are used for treating sepsis using HDL-NP.